Neuphoria TherapeuticsNEUP
那斯達克 · USD
4.78
+0.06
(+1.27%)
收盤 04/11 03:34 (UTC+8)
04/11 03:34 (UTC+8)
Neuphoria TherapeuticsNEUP
4.78
+0.06
(+1.27%)
財務數據
損益表
- -
- 0.00
- 0.00
- 0.00
- 0.00
- -
- 0.01
- 0.15
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 2162.44
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | 15,000 | 663 | - | 0 | 0 | 0 | 0 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | 15,000 | 663 | - | 0 | 0 | 0 | 0 | - |
營業費用 | 4,061 | 5,653 | 3,023 | 4,366 | 3,568 | 5,478 | 2,394 | 4,458 | 5,468 | - |
研發費用 | 698 | 3,786 | 1,616 | 1,737 | 1,901 | 3,096 | 1,199 | 2,035 | 3,088 | - |
推銷及管理費用 | 2,127 | 1,867 | 1,407 | 2,629 | 1,667 | 2,382 | 1,195 | 2,518 | 2,379 | - |
非經常性項目費用 | 1,236 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | 0 | 0 | -95 | - | - |
營業利益 | -4,061 | -5,653 | 11,977 | -3,704 | -3,568 | -5,478 | -2,394 | -4,458 | -5,468 | - |
其他收入及費用 | 5,890 | -4,289 | -796 | 1,772 | 2,631 | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 1,829 | -9,941 | 11,181 | -1,932 | -937 | -2,721 | -2,762 | -4,589 | -5,507 | - |
所得稅 | -35 | -35 | -81 | 12 | -132 | -34 | 16 | -35 | -35 | - |
稅後純益 | 1,864 | -9,907 | 11,262 | -1,943 | -805 | -2,687 | -2,778 | -4,554 | -5,473 | - |
基本每股稅後盈餘(元) | 0.41 | -4.41 | 6.55 | -1.23 | -0.62 | - | -2.83 | -5.31 | -0.04 | - |
稀釋每股稅後盈餘(元) | 1.75 | -4.41 | 8.34 | -3.97 | -0.62 | - | -2.83 | -5.31 | -0.04 | - |
基本平均股數(千股) | 4536.00 | 2246.00 | 1719.00 | 1575.00 | 1300.00 | - | 981.00 | 857.00 | 124666.00 | - |
稀釋平均股數(千股) | 4536.00 | 2246.00 | 1719.00 | 1575.00 | 1300.00 | - | 981.00 | 857.00 | 124666.00 | - |
還原基本每股稅後盈餘(元) | 0.41 | -4.41 | 6.55 | -1.23 | -0.62 | - | -2.83 | -5.31 | -0.04 | - |
還原稀釋每股稅後盈餘(元) | 1.75 | -4.41 | 8.34 | -3.97 | -0.62 | - | -2.83 | -5.31 | -0.04 | - |
還原基本平均股數(千股) | 4,536 | 2,246 | 1,719 | 1,575 | 1,300 | - | 981 | 857 | 124,666 | - |
還原稀釋平均股數(千股) | 4,536 | 2,246 | 1,719 | 1,575 | 1,300 | - | 981 | 857 | 124,666 | - |
EBITDA(千元) | 1,995 | -9,776 | 11,346 | -1,765 | -771 | -2,555 | -2,596 | -4,423 | -5,342 | 0 |